WI
Windtree Therapeutics, Inc.
WINT · OTC
$0.00 -33.33% (-$0.00)
1M +100.00%
Market Cap $10.1K
P/E Ratio -
Div. Yield -
ROE 1,302.82%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.11x
EV/EBITDA N/A
P/B N/A
Growth
0 /100
Declining Book val. growth 37.97%
Rev. growth N/A
FCF growth N/A
Profitability
0 /100
Weak Net margin 44,447.80%
Op. margin 37,218.90%
FCF margin 16,801.10%
Quality
0 /100
Poor ROE 1,302.82%
ROA 250.29%
Asset turnover 0.01x
Debt
0 /100
High Int. coverage -88.14x
Current ratio 0.33x
Net debt/EBITDA N/A
Stability
44 /100
Moderate EPS volatility 23.45%
Profitable years 0
Beta 1.60x
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o WINT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jed A. Latkin
Employees
14
Headquarters
Warrington
Nadchodzące wydarzenia
26 LIS
Earnings
Upcoming earnings report